Home > Industry Projects > Americas > ImClone Systems Biopharmaceutical Plant
ImClone has a portfolio of targeted biologic treatments designed to address a variety of cancers.
Copyright 2007SPG Media Limited a subsidiary of SPG Media Group PLC
